Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.06.24.733783

The Hidden Disorder Divide: Reconciling Benchmark Inconsistencies in Intrinsically Disordered Protein Binding Site Prediction

Abstract

Computational predictors of protein-binding sites within intrinsically disordered regions (IDRs) show highly inconsistent performance across high-quality benchmark datasets. To understand the origins of these discrepancies, we systematically compared predictors across three independent test sets: two CAID datasets updated with the latest DisProt annotations and a composite dataset (DBs) assembled from DIBS, FuzDB, IDEAL, and MFIB. Predictors trained predominantly on DisProt data achieved substantially higher AUCs on the CAID sets but performed poorly on the DBs. In contrast, predictors trained on older, low-quality PDB-based datasets showed balanced performance across all sets, with a slight preference for DBs. Predictors with mixed training exposure displayed intermediate behavior. Through controlled experiments using identical CNN architectures and feature analysis, we demonstrate that the dominant factor driving these performance differences is the intrinsic disorder propensity of the binding sites themselves. Binding residues in DisProt-based datasets exhibit markedly higher average disorder propensity scores than those in PDB-derived datasets. This previously unrecognized selection bias -- literature studies preferentially characterizing more disordered binding sites, while PDB-derived annotations capture less disordered ones -- effectively splits IDR-protein binding sites into two distinct categories. Predictors optimized on one category therefore generalize poorly to the other. Binding-site length and sequence conservation play only minor or negligible roles in explaining the observed inconsistencies. These findings highlight a critical limitation in current benchmarking practices and training strategies for IDR-binding site prediction, underscoring the need for more balanced and disorder-aware reference datasets. Finally, the diagnostic techniques introduced here could prove valuable beyond the specific application examined in this study. The data and code used to generate all figures and tables are available at: https://github.com/NawarMalhis/HDD

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Malhis, N., Mehdiabadi, M., Erdos, G., Gsponer, J., Kurgan, L., Tosatto, S. C. E., Dosztanyi, Z., Piovesan, D.. 2026-06-27. The Hidden Disorder Divide: Reconciling Benchmark Inconsistencies in Intrinsically Disordered Protein Binding Site Prediction. https://doi.org/10.64898/2026.06.24.733783

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗